Overview
The I3h Institute operates as an institute for interdisciplinary innovation in healthcare, offering educational programs, conducting research, and organizing conferences on topics including translational medicine, advanced therapies, and vaccine development. The institute is affiliated with ULB (Université Libre de Bruxelles) and hosts seminars, lectures, and training programs.
In the news
- MEET THE SPEAKERS | AI and the Future of European Frontier Research and Innovation in Health On 25 November 2026, the I3h Institute will bring together experts from academia, the health innovation ecosystem and European institutions to explore the future of AI-driven research and innovation in Europe. 🔎 Meet our speakers: - Hugues Bersini: Professor of Artificial Intelligence at Université libre de Bruxelles and FARI - AI for the Common Good Institute - Niklas Blomberg: Executive Director of the Innovative Health Initiative (IHI)
- MEET THE SPEAKERS | AI and the Future of European Frontier Research and Innovation in Health On 25 November 2026, the I3h Institute will bring together experts from academia, the health innovation ecosystem and European institutions to explore the future of AI-driven research and innovation in Europe. 🔎 Meet our speakers: - Hugues Bersini: Professor of Artificial Intelligence at Université libre de Bruxelles and FARI - AI for the Common Good Institute - Niklas Blomberg: Executive Director of the Innovative Health Initiative (IHI)
- Join us for the next I3h Reading Seminar! On November 16, we are pleased to welcome Nicolas van Zeebroeck, Professor of Digital Economics & Strategy at Solvay Brussels School of Economics and Management (Université libre de Bruxelles) who will present his joint work with Jean-Michel Hougardy, General Medical Director of Hôpital Universitaire de Bruxelles (H.U.B) - Academisch Ziekenhuis Brussel (H.U.B). ➡️ He will give a talk entitled: “When generative AI precedes the clinical encounter: informational shifts,
- The Kurgan-van Hentenryk chair and the I3h Institute of Université libre de Bruxelles (ULB) invite you to a conference on "AI and the future of European Frontier Research and Innovation in Health" The 2024 Draghi Report worries about lagging relative European productivity in general. While stressing strengths in our health sector, it highlights risks in key (fast-growing) frontier subsectors. The conference could assess the extent to which AI, where Europe is significantly behind the US and China, will accelerate these
- FORUM: Bénéfices et coûts des traitements innovants : un défi sociétal. Le point de vue des patients, des cliniciens, de l’industrie et des payeurs. Un symposium consacré à l’efficacité et au coût des thérapies innovantes en neurologie et en psychiatrie. Cette conférence visera à confronter les points de vue des patients, cliniciens, industriels et payeurs sur les bénéfices cliniques, la tolérance et l’accessibilité financière de ces nouveaux traitements, en cohérence avec la mission du Belgian Brain Council de rassembler l’ensemble
- REGISTER NOW
- Join us for the first I3h Reading Seminar of the academic year! On September 29, we are pleased to welcome Shiri Mermelstein, PhD candidate at Solvay Brussels School of Economics and Management (Université libre de Bruxelles) and I3h Institute. ➡️ She will give a talk entitled: “The long-run effects of public and philanthropic research subsidies on inequalities in pharmaceutical development" Public and philanthropic research funding stimulates private medical R&D via spillovers and risk-sharing, influencing which medicines
- Proud of our student!
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.